PharmStars Ventures

MD from Imperial College London with decades of experience in startups and pharma digital health. Co-founder and general partner of PharmStars Ventures Fund. Managing Director of Strategy Health consulting firm. Previously Vice President of Clinical Transformation at RxHealth and Clinical Transformation Lead at Mount Sinai's AppLab.

Over 25 years of leadership roles in the digital industry at large global companies including Intel and Perion. Former Head of R&D Products of Digital Health at Takeda and Head of Digital Health Products at Teva where he led development of an FDA-approved respiratory product. Trained yoga teacher who coaches organizations on decision-making.

Over 20 years of experience in pharmaceutical R&D, drug discovery services, healthcare technology, and private equity-backed healthcare businesses. Chartered Accountant with expertise as COO, board member, and healthcare advisor. Previously Chief Operating Officer at Sygnature Discovery and senior leader at IQVIA and GSK.

Healthcare technology leader with over 25 years of experience at the intersection of AI, public health, and enterprise strategy. President and Co-Founder of AdirA LLC. Served as Chief Digital Officer at Merck, Chief Information Officer at ILÚM Health Solutions, and Chairwoman of the NSF-sponsored ASSIST Center.

Founder of Keystone Experience Initiative, an experience transformation and management consulting business. Over 30 years of experience at Eli Lilly and Company in marketing, sales, and business strategy transformation. Serves on multiple boards and commissions globally and locally.

Healthcare executive with 15+ years of clinical and industry experience. Started career as faculty at Brown University and Massachusetts College of Pharmacy. Served as Senior Vice President of Commercial at Pack Health. Co-Founder and Partner at Taurus Health. PharmD from Massachusetts College of Pharmacy.

Bio-pharma industry veteran with over 35 years of business, information technology, and cyber-security experience. Former Senior Vice President and Chief Information Officer of Alexion Pharmaceuticals. Previously Vice President and business line CIO at Merck. Serves on boards at Charles River Laboratories and NCWIT.

Over 20 years spanning large pharmaceutical companies and early-stage VC-backed ventures. Brings expertise in finance, strategy, and cross-functional leadership in R&D, manufacturing, commercial, and digital health. Recently Vice President of Corporate Strategy and Development at Evidation Health after nearly two decades at Eli Lilly.

PhD in genetics from Harvard Medical School with varied career in academia, pharma, biotech, and nonprofit. Spent 15 years at BASF/Abbott as scientist and group leader, then held senior roles at RXi and served as Executive Director/CEO of Addgene. Leader in creating group mentoring programs and diversity, equity, and inclusion consulting.

PhD in microbiology from University of Texas at Austin with over a decade of experience spanning life science research, education, writing, and healthcare industry. Founded a life science marketing consulting business and created Joyful Microbe platform. Previously conducted genomics and transcriptomics research on antimicrobial resistance.

Seasoned executive with deep clinical research expertise in building efficient divisions and transforming global organizations. Former Global Vice President Clinical Innovation at Oracle Life Sciences. Previously Chief Ecosystem Officer at Reify Health and held 30-year career at Eli Lilly in clinical operations and data sciences.

Career spanning storytelling and communications, starting as Bloomberg reporter covering healthcare and pharma. Held leadership roles at Johnson & Johnson managing media relations and corporate communications. Founded Mint Collective communications consultancy and teaches at The College of New Jersey.

Seasoned pharmaceutical executive with over 30 years of financial management, commercial operations, and organizational leadership experience. Currently Senior Vice President at Sumitomo Pharma America. President of OE Associates LLC advising pharmaceutical companies on strategic and operational initiatives.

Business consultant with over 25 years of experience in organizational and professional development, strategic planning, and project management. Brings expertise in program development and implementation. Previously Planning and Projects Coordinator at Health Innovation Strategies.

Visionary problem solver serving as advisor, investor, entrepreneur, and corporate executive. Chief Executive of Emerge Inc. Previously Chief Innovation Officer at Cambia Health Solutions where he accelerated culture transformation and created six startups in ten years. Published author and adjunct professor at Kellogg School of Management.

First chief innovation officer at Children's Hospital Los Angeles responsible for fostering innovation across clinical and research enterprises. Founder and Managing Director of KidsX, the first national pediatric digital health accelerator. Previously Executive Director of the Cedars-Sinai Accelerator powered by Techstars.

Founder and CEO of Viventi Advisors helping rare disease founders validate commercial assumptions. Over 13 years in pharma and biotech with 10+ focused on rare disease, overseeing $50B+ in revenue operations. Previously held commercial finance leadership at Alexion, Akcea Therapeutics, Gilead Sciences, and Intarcia.

Senior Director of Partnerships, Programming, & Community at LabCentral overseeing business development strategy and resident company growth. Previously led the MassCONNECT mentoring program at MassBio matching life sciences entrepreneurs with seasoned professionals. International Business Development experience with Canadian Consulate and Canadian Technology Accelerator.

MD with over 30 years of US and global pharma experience in regulatory approvals, product launches, and R&D transformations. Worked across Hoechst Roussel, Pierre Fabre, Roche, Pfizer, Roivant, and Sumitovant. Currently Chief Medical Officer at MBX Biosciences.

Recognized pioneer in digital health and health innovation with nearly 20 years of experience leading digital strategy in biopharma and agencies. Former Head of Global Digital Strategy at Bristol Myers Squibb and co-founder of Novartis BIOME's Open Innovation. Involved in health tech startup ecosystem for over 10 years.

Advisor and investor in health tech space with leadership experience across biotech, pharma, healthcare, and life sciences. Served as Senior Vice President and Global Head of Digital Innovation at Sumitovant and Chief Analytics Officer at Healthfirst. Previously held roles at Pfizer, Charles River Labs, and PA Consulting Group.

Over 20 years of business and technical experience spanning pharma, big tech, and digital health. Chief Business Officer for Portal Instruments. Previously Chief Commercial Officer at Beta Bionics and Vice President of External Innovation at Eli Lilly. Chemical Engineer with PhD from Stanford and MBA from Darden.

Over 15 years of experience across large healthcare, biopharma enterprises and startup ventures. Global Healthcare Industry Leader at Automation Anywhere. Previously Medical Director for Digital Medicine at Amgen leading digital biomarkers research and clinical trial modernization. National Director of Innovation at Kaiser Permanente through 2014.